Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
Phase 1
Suspended
- Conditions
- Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
- Interventions
- First Posted Date
- 2020-05-07
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 64
- Registration Number
- NCT04379518
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Consumer Assessment of Tobacco Flavor and Odor
Active, not recruiting
- Conditions
- Current VaperHealthy Subject
- Interventions
- Behavioral: Behavioral InterventionOther: Questionnaire Administration
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 29
- Registration Number
- NCT04358315
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
Phase 2
Recruiting
- Conditions
- Metastatic Triple-Negative Breast CarcinomaAnatomic Stage IV Breast Cancer AJCC v8Metastatic Malignant Neoplasm in the BrainPrognostic Stage IV Breast Cancer AJCC v8
- Interventions
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 23
- Registration Number
- NCT04348747
- Locations
- πΊπΈ
Moffitt Cancer Center, Tampa, Florida, United States
πΊπΈMoffitt Cancer Center, Tampa, Florida, United States
πΊπΈRoswell Park Cancer Institute, Buffalo, New York, United States
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence
Early Phase 1
Recruiting
- Conditions
- Stage IIA Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Chronic Obstructive Pulmonary DiseasePneumoniaStage II Lung Cancer AJCC v8Lung Non-Small Cell CarcinomaStage IIB Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8
- Interventions
- Other: Quality-of-Life AssessmentOther: Questionnaire AdministrationBiological: Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
- First Posted Date
- 2020-03-06
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 60
- Registration Number
- NCT04298606
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
Not Applicable
Completed
- Conditions
- Metastatic Breast CarcinomaBreast CarcinomaRecurrent Breast CarcinomaAnatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8
- Interventions
- Other: Informational InterventionOther: Quality-of-Life AssessmentOther: Survey Administration
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 174
- Registration Number
- NCT04297384
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Episodic Future Thinking and Future Thinking Priming for Smoking Cessation
Not Applicable
Terminated
- Conditions
- Tobacco-Related Carcinoma
- Interventions
- Behavioral: Behavioral InterventionOther: Informational InterventionOther: Telephone-Based Intervention
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 26
- Registration Number
- NCT04297332
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Web-Based Lifestyle Intervention for the Improvement of Health in African American Cancer Survivors
Not Applicable
Withdrawn
- Conditions
- Cancer Survivor
- Interventions
- Behavioral: Lifestyle TherapyOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Roswell Park Cancer Institute
- Registration Number
- NCT04290962
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old
Phase 2
Recruiting
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Myelodysplasia-Related ChangesSecondary Acute Myeloid LeukemiaTherapy-Related Acute Myeloid Leukemia
- Interventions
- Drug: Liposome-encapsulated Daunorubicin-Cytarabine
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 46
- Registration Number
- NCT04269213
- Locations
- πΊπΈ
University of Nebraska Medical Center, Omaha, Nebraska, United States
πΊπΈRoswell Park Cancer Institute, Buffalo, New York, United States
πΊπΈSUNY Upstate Medical Center, Syracuse, New York, United States
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
Not Applicable
Active, not recruiting
- Conditions
- Nicotine Dependence
- Interventions
- Device: Vaporizer Device
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 20
- Registration Number
- NCT04231539
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid Leukemia
Phase 1
Completed
- Conditions
- Refractory Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia
- Interventions
- Other: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2019-12-20
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 24
- Registration Number
- NCT04207190
- Locations
- πΊπΈ
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States
πΊπΈRoswell Park Cancer Institute, Buffalo, New York, United States